Free Trial

Immix Biopharma (IMMX) Earnings Date, Estimates & Call Transcripts

Immix Biopharma logo
$1.97 -0.02 (-1.01%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$1.96 -0.01 (-0.76%)
As of 06:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immix Biopharma Earnings Summary

Immix Biopharma announced Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.16, which beat the consensus estimate of -$0.25 by $0.09. With a trailing EPS of -$0.70, Immix Biopharma's earnings are expected to grow next year, from ($0.87) to ($0.85) per share.

Upcoming
Earnings Date
Aug. 11Before Market OpensEstimated
Consensus EPS
(Mar. 24)
-$0.25
Actual EPS
(Mar. 24)
-$0.16 Beat By $0.09

Q4 2024 Earnings Resources

IMMX Upcoming Earnings

Immix Biopharma's next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules.

Get Immix Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Immix Biopharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IMMX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Immix Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.23-$0.23-$0.23
Q2 20251-$0.21-$0.21-$0.21
Q3 20251-$0.22-$0.22-$0.22
Q4 20251-$0.20-$0.20-$0.20

Immix Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2025
(Estimated)
--------
3/24/2025Q4 2024-$0.25-$0.16+$0.09-$0.16--
11/12/2024--$0.16-$0.24 -$0.08-$0.24--
8/12/2024--$0.21-$0.15+$0.06-$0.15--
5/9/2024Q1 2024-$0.23-$0.22+$0.01-$0.22--
3/29/2024Q4 2023--$0.24 -$0.24-$0.24--
11/9/2023Q3 2023-$0.23-$0.23--$0.23--
8/11/2023Q2 2023-$0.17-$0.24 -$0.07-$0.24--

Immix Biopharma Earnings - Frequently Asked Questions

Immix Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on IMMX's earnings history.

In the previous quarter, Immix Biopharma (NASDAQ:IMMX) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.09. Learn more on analysts' earnings estimate vs. IMMX's actual earnings.

Immix Biopharma (NASDAQ:IMMX) has a recorded net income of -$15.43 million. IMMX has generated -$0.70 earnings per share over the last four quarters.

Immix Biopharma's earnings are expected to grow from ($0.87) per share to ($0.85) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:IMMX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners